Background illustration for clinical trials search

Paid Clinical Trials Wilmington

Discover 265 paid clinical trials in Wilmington, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Wilmington DE, Washington D.C. DC, Lake Success NY,
Sponsor: Ascendis Pharma A/S

Sex: All

Age: 2 - 17

Code: NCT07221851

Phase 3, Recruiting
Active & ResponsiveNew

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets

for
Idiopathic Pulmonary Fibrosis
Location: Wilmington DE, Charlotte NC, North Miami Beach FL,
Sponsor: Trevi Therapeutics

Sex: All

Age: 40+

Code: NCT07868419

Phase 3, Recruiting
Active & Responsive

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Newark DE, Baltimore MD, New York NY, New Haven CT,
Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT06747117

Recruiting
Active & Responsive

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for
Colorectal Cancer
Location: Newark DE, Philadelphia PA, Pennington NJ, Baltimore MD,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06562543

Recruiting
Active & Responsive

Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

for
Endometriosis
Location: Newark DE, Baltimore MD, Valley Stream NY, Lynchburg VA,
Sponsor: Aspira Women's Health

Sex: Female

Age: 14 - 50

Code: NCT05245695

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Newark DE, Philadelphia PA, Sewell NJ, Willow Grove PA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Newark DE, Philadelphia PA, East Brunswick NJ,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase 3, Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Newark DE, Philadelphia PA, Rehoboth Beach DE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase 3, Recruiting
Active & Responsive

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for
Advanced Esophageal Adenocarcinoma,
Location: Newark DE, Philadelphia PA, Sewell NJ, Cherry Hill NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06203600

Phase 2, Phase 3, Recruiting
Active & Responsive

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Newark DE, Alexandria VA, New York NY, Fairfax VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05136196

Phase 2, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Newark DE, Baltimore MD, Newark NJ, New York NY,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase 2, Phase 3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Newark DE, Baltimore MD, New Brunswick NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase 3, Recruiting
Active & Responsive

Bundled Cancer Screening and Genetic Services Navigation

for
Breast Cancer Screening, Colon Cancer Screening,
Location: Newark DE, Washington D.C. DC
Sponsor: Georgetown University

Sex: Female

Age: 45 - 70+

Code: NCT07228000

Recruiting
Active & Responsive

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Newark DE, Philadelphia PA, Towson MD, Baltimore MD,
Sponsor: Massive Bio, Inc.

Sex: All

Age: 0+

Code: NCT03452774

Recruiting
Active & Responsive

Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women

for
Estrogen, Premenopause
Location: Newark DE
Sponsor: University of Delaware

Sex: Female

Age: 40 - 55

Code: NCT06745466

Recruiting
Active & Responsive

Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans

for
Cardiovascular Risk Factor
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 18 - 45

Code: NCT04101188

Recruiting
Active & Responsive

Positive Processes and Transition to Health (PATH)

for
Posttraumatic Stress Disorder, Major Depressive Disorder
Location: Newark DE, Cleveland OH, Seattle WA
Sponsor: Case Western Reserve University

Sex: All

Age: 18 - 65

Code: NCT06093906

Recruiting
Active & Responsive

HIT-Stroke Trial 2

for
Stroke
Location: Newark DE, Cincinnati OH, Kansas City KS
Sponsor: University of Cincinnati

Sex: All

Age: 30 - 70+

Code: NCT06268041

Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Dover DE, Trenton NJ, Annapolis MD, Harrisburg PA,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

for
Arthritis, Rheumatoid
Location: Wyomissing PA, Lewes DE, Berkeley Heights NJ, Summit NJ,
Sponsor: Crescendo Bioscience

Sex: All

Age: 18 - 70+

Code: NCT02832297

Recruiting